Published in PLoS One on October 24, 2011
The role of potassium channel activation in celecoxib-induced analgesic action. PLoS One (2013) 0.82
Class 3 inhibition of hERG K+ channel by caffeic acid phenethyl ester (CAPE) and curcumin. Pflugers Arch (2013) 0.78
Inhibition of ion channels and heart beat in Drosophila by selective COX-2 inhibitor SC-791. PLoS One (2012) 0.77
Evidence of more ion channels inhibited by celecoxib: KV1.3 and L-type Ca(2+) channels. BMC Res Notes (2015) 0.77
Acute and chronic toxicity, cytochrome p450 enzyme inhibition, and HERG channel blockade studies with a polyherbal, ayurvedic formulation for inflammation. Biomed Res Int (2015) 0.76
3-D structural interactions and quantitative structural toxicity studies of tyrosine derivatives intended for safe potent inflammation treatment. Chem Cent J (2016) 0.75
COX-2-selective inhibitors celecoxib and deracoxib modulate TRPV3 channels. Br J Pharmacol (2017) 0.75
A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell (1995) 10.18
Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature (1996) 9.77
SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell (1995) 7.73
Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet (1996) 7.35
HERG, a human inward rectifier in the voltage-gated potassium channel family. Science (1995) 7.26
hERG potassium channels and cardiac arrhythmia. Nature (2006) 6.63
KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science (2003) 6.60
Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature. Biophys J (1998) 3.83
Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation (2003) 3.68
Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. Circulation (2004) 2.82
Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels. J Pharmacol Exp Ther (2000) 2.47
A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia. Nat Med (2009) 2.37
Class III antiarrhythmic drugs block HERG, a human cardiac delayed rectifier K+ channel. Open-channel block by methanesulfonanilides. Circ Res (1996) 2.05
Differential effects of selective cyclooxygenase-2 inhibitors on vascular smooth muscle ion channels may account for differences in cardiovascular risk profiles. Mol Pharmacol (2009) 2.00
High affinity open channel block by dofetilide of HERG expressed in a human cell line. Mol Pharmacol (1996) 1.91
Voltage-dependent inactivation of the human K+ channel KvLQT1 is eliminated by association with minimal K+ channel (minK) subunits. J Physiol (1998) 1.88
Biology of cardiac arrhythmias: ion channel protein trafficking. Circ Res (2004) 1.87
Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor. Clin Pharmacokinet (2000) 1.76
The hERG potassium channel and hERG screening for drug-induced torsades de pointes. Pharmacol Ther (2008) 1.72
KvLQT1, a voltage-gated potassium channel responsible for human cardiac arrhythmias. Proc Natl Acad Sci U S A (1997) 1.70
Organization of ventricular fibrillation in the human heart. Circ Res (2007) 1.69
Long QT syndrome in neonates: conduction disorders associated with HERG mutations and sinus bradycardia with KCNQ1 mutations. J Am Coll Cardiol (2004) 1.30
The hERG K+ channel: target and antitarget strategies in drug development. Pharmacol Res (2008) 1.22
Inhibition of delayed rectifier potassium channels and induction of arrhythmia: a novel effect of celecoxib and the mechanism underlying it. J Biol Chem (2007) 1.09
Endoplasmic reticulum retention and rescue by heteromeric assembly regulate human ERG 1a/1b surface channel composition. J Biol Chem (2007) 0.98
Ventricular arrhythmias after left ventricular assist device implantation. Pacing Clin Electrophysiol (2008) 0.97
Celecoxib inhibits Na+ currents in rat dorsal root ganglion neurons. Brain Res (2007) 0.95
Preferential closed channel blockade of HERG potassium currents by chemically synthesised BeKm-1 scorpion toxin. FEBS Lett (2003) 0.94
Effects of celecoxib on voltage-gated calcium channel currents in rat pheochromocytoma (PC12) cells. Pharmacol Res (2007) 0.94
Celecoxib blocks cardiac Kv1.5, Kv4.3 and Kv7.1 (KCNQ1) channels: effects on cardiac action potentials. J Mol Cell Cardiol (2010) 0.93
Interactions of the narcotic l-alpha-acetylmethadol with human cardiac K+ channels. Eur J Pharmacol (2003) 0.93
Mutations in cardiac sodium channels: clinical implications. Am J Pharmacogenomics (2003) 0.92
Mechanisms of Kv2.1 channel inhibition by celecoxib--modification of gating and channel block. Br J Pharmacol (2009) 0.89
Effects of celecoxib on ionic currents and spontaneous firing in rat retinal neurons. Neuroscience (2008) 0.88
Transcriptional profiling of ion channel genes in Brugada syndrome and other right ventricular arrhythmogenic diseases. Eur Heart J (2008) 0.85
Early clinical development: evaluation of drug-induced torsades de pointes risk. Pharmacol Ther (2008) 0.82
Induction of a fast inactivation gating on delayed rectifier Shab K(+) channels by the anti-inflammatory drug celecoxib. Channels (Austin) (2011) 0.81
Drug-induced QT interval prolongation: regulatory perspectives and drug development. Ann Med (2004) 0.81
Mechanism of K(v)2.1 channel inhibition by a selective COX-2 inhibitor SC-791-modification of gating. Brain Res (2010) 0.80
Skeletal metastasis in gall bladder cancer. HPB (Oxford) (2007) 1.48
Inhibition of delayed rectifier potassium channels and induction of arrhythmia: a novel effect of celecoxib and the mechanism underlying it. J Biol Chem (2007) 1.09
Mutations in cytochrome c oxidase subunit VIa cause neurodegeneration and motor dysfunction in Drosophila. Genetics (2007) 0.92
Expression of alternative oxidase in Drosophila ameliorates diverse phenotypes due to cytochrome oxidase deficiency. Hum Mol Genet (2013) 0.91
Isolated posterior wall gastric rupture in blunt trauma to abdomen. Indian J Gastroenterol (2005) 0.91
Modulation of L-type calcium channels in Drosophila via a pituitary adenylyl cyclase-activating polypeptide (PACAP)-mediated pathway. J Biol Chem (2004) 0.86
Mechanism of K(v)2.1 channel inhibition by a selective COX-2 inhibitor SC-791-modification of gating. Brain Res (2010) 0.80
Biochemical and structural characterization of recombinant hyoscyamine 6β-hydroxylase from Datura metel L. Plant Physiol Biochem (2010) 0.78
Potassium channels in Drosophila: historical breakthroughs, significance, and perspectives. J Neurogenet (2012) 0.77
Temperature and functional plasticity of L-type Ca2+ channels in Drosophila. Cell Calcium (2013) 0.77
Inhibition of ion channels and heart beat in Drosophila by selective COX-2 inhibitor SC-791. PLoS One (2012) 0.77
Surgical management of complications associated with percutaneous and/or endoscopic management of pseudocyst of the pancreas. Ann Surg (2006) 0.75
A masquerade presenting with diplopia. Aust Fam Physician (2014) 0.75